Gallic acid exerts a protective or an anti-proliferative effect on glioma T98G cells via dose-dependent epigenetic regulation mediated by miRNAs

International Journal of Oncology

Volumn 46, Issue 4, 2015, Pages 1491-1497

  Paolini, Alessandro ^a   Curti, Valeria ^a   Pasi, Francesca ^a   Mazzini, Giuliano ^a   Nano, Rosanna ^a   Capelli, Enrica ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Cytotoxic effects; Gallic acid; Glioblastoma; miRNAs

Indexed keywords

ATM PROTEIN; GALLIC ACID; MICRORNA; MITOCHONDRIAL ENZYME; PROTEIN P21; ANTINEOPLASTIC AGENT; MIRN17 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; MIRN421 MICRORNA, HUMAN; MITOCHONDRIAL PROTEIN;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER GROWTH; CELL MIGRATION; CONTROLLED STUDY; CORRELATIONAL STUDY; EPIGENETICS; GENE EXPRESSION; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; BRAIN NEOPLASMS; CELL MOTION; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIGENESIS, GENETIC; GALLIC ACID; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MICRORNAS; MITOCHONDRIAL PROTEINS;

EID: 84923116150     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.2864     Document Type: Article

References (41)

1. BURGER PC, HEINZ ER, SHIBATA T and KLEIHUES P: Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68: 698-704, 1988.
2. MILLER CR and PERRY A: Glioblastoma. Arch Pathol Lab Med 131: 397-406, 2007.
3. KILIC T, ALBERTA JA, ZDUNEK PR, ACAR M, IANNARELLI P, O'REILLY T, BUCHDUNGER E, BLACK PM and STILES CD: Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma Cell growth by an orally active kinase inhibitor of the 2-phenylami-nopyrimidine class. Cancer Res 60: 5143-5150, 2000.
4. MUKHTAR H and AHMAD N: Tea polyphenols: Prevention of Cancer and optimizing health. Am J Clin Nutr 71: 1698S-1702S, 2000.
5. FRESCO P, BORGES F, DINIZ C and MARQUES MP: New insights on the Anticancer properties of dietary polyphenols. Med Res Rev 26: 747-766, 2006.
6. SURH YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3: 768-780, 2003.
7. KONG AN, YU R, HEBBAR V, CHEN C, OWUOR E, HU R, EE R and MANDLEKAR S: Signal transduction events elicited by Cancer prevention compounds. Mutat Res 480-481: 231-241, 2001.
8. JI BC, HSU WH, YANG JS, HSIA TC, LU CC, CHIANG JH, YANG JL, LIN CH, LIN JJ, SUEN LJ, GIBSON WOOD W and CHUNG JG: Gallic acid induces apoptosis via caspase-3 and mitochondrion-dependent pathways in vitro and suppresses lung xenograft tumor growth in vivo. J Agric Food Chem 57: 7596-7604, 2009.
9. LIU Z, LI D, YU L and NIU F: Gallic acid as a cancer-selective agent induces apoptosis in pancreatic Cancer cells. Chemotherapy 58: 185-194, 2012.
10. BARTEL DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
11. CURTI V, CAPELLI E, BOSCHI F, NABAVI SF, BONGIORNO AI, HABTEMARIAM S, NABAVI SM and DAGLIA M: Modulation of human miR-17-3p expression by methyl 3-O-methyl gallate as explanation of its in vivo protective activities. Mol Nutr Food Res 58: 1776-1784, 2014.
12. VALADI H, EKSTRÖM K, BOSSIOS A, SJÖSTRAND M, LEE JJ and LÖTVALL JO: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659, 2007.
13. ASANGANI IA, RASHEED SA, NIKOLOVA DA, LEUPOLD JH, COLBURN NH, POST S and ALLGAYER H: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136, 2008.
14. HIYOSHI Y, KAMOHARA H, KARASHIMA R, SATO N, IMAMURA Y, NAGAI Y, YOSHIDA N, TOYAMA E, HAYASHI N, WATANABE M and BABA H: MicroRNA-21 regulates the proliferation and invasion in esophageal squamous Cell carcinoma. Clin Cancer Res 15: 1915-1922, 2009.
15. SHI L, CHENG Z, ZHANG J, LI R, ZHAO P, FU Z and YOU Y: Hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res 1236: 185-193, 2008.
16. WEISS FU, MARQUES IJ and WOLTERING JM: Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology 137: 2136-2145, 2009.
17. LU Y, JIANG F, JIANG H, WU K, ZHENG X, CAI Y, KATAKOWSKI M, CHOPP M and TO SS: Gallic acid suppress Cell viability, proliferation, invasion and angiogenesis in human glioma cells. Eur J Pharmacol 641: 102-107, 2010.
18. LEE SH, KIM JK, KIM DW, HWANG HS, EUM WS, PARK J, HAN KH, OH JS and CHOI SY: Antitumor activity of methyl gallate by inhibition of focal adhesion formation and Akt phosphorylation in glioma cells. Biochim Biophys Acta 1830: 4017-4029, 2013.
19. SAKAGAMI H and SATOH K: Prooxidant action of two antioxidants: Ascorbic acid and gallic acid. Anticancer Res 17: 221-224, 1997.
20. STRLIC M, RADOVIC T, KOLAR J and PIHLAR B: Anti-and prooxidative properties of gallic acid in fenton-type systems. J Agric Food Chem 50: 6313-6317, 2002.
21. CHEN HM, WU YC, CHIA YC, CHANG FR, HSU HK, HSIEH YC, CHEN CC and YUAN SS: Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate Cancer cells. Cancer Lett 286: 161-171, 2009.
22. SAVI LA, LEAL PC, VIEIRA TO, ROSSO R, NUNES RJ, YUNES RA, CRECZYNSKI-PASA TB, BARARDI CR and SIMÕES CM: Evaluation of anti-herpetic and antioxidant activities, and cytotoxic and genotoxic effects of synthetic alkyl-esters of gallic acid. Arzneimittelforschung 55: 66-75, 2005.
23. KROES BH, VAN DEN BERG AJ, QUARLES VAN UFFORD HC, VAN DIJK H and LABADIE RP: Anti-inflammatory activity of gallic acid. Planta Med 58: 499-504, 1992.
24. GICHNER T, POSPÍSIL F, VELEMÍNSKÝ J, VOLKEOVÁ V and VOLKE J: Two types of antimutagenic effects of gallic and tannic acids towards N-nitroso-compounds-induced mutagenicity in the Ames Salmonella assay. Folia Microbiol 32: 55-62, 1987.
25. MIRVISH SS, CARDESA A, WALLCAVE L and SHUBIK P: Induction of mouse lung adenomas by amines or ureas plus nitrite and by N-nitroso compounds: Effect of ascorbate, gallic acid, thiocya-nate and caffeine. J Natl Cancer Inst 55: 633-636, 1975.
26. INOUE M, SUZUKI R, SAKAGUCHI N, LI Z, TAKEDA T, OGIHARA Y, JIANG BY and CHEN Y: Selective induction of Cell death in Cancer cells by gallic acid. Biol Pharm Bull 18: 1526-1530, 1995.
27. FOX JT, SAKAMURU S, HUANG R, TENEVA N, SIMMONS SO, XIA M, TICE RR, AUSTIN CP and MYUNG K: High-throughput geno-toxicity assay identifes antioxidants as inducers of DNA damage response and Cell death. Proc Natl Acad Sci USA 109: 5423-5428, 2012.
28. ZHANG X, LADD A, DRAGOESCU E, BUDD WT, WARE JL and ZEHNER ZE: MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection. Clin Exp Metastasis 26: 965-979, 2009.
29. XU Y, FANG F, ZHANG J, JOSSON S, ST CLAIR WH and ST CLAIR DK: Mir-17∗ suppresses tumorigenicity of prostate Cancer by inhibiting mitochondrial antioxidant enzymes. PLoS One 5: E14356, 2010.
30. PAPAGIANNAKOPOULOS T, SHAPIRO A and KOSIK KS: MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblas-toma cells. Cancer Res 68: 8164-8172, 2008.
31. HU H, DU L, NAGABAYASHI G, SEEGER RC and GATTI RA: ATM is down-regulated by N-Myc-regulated microRNA-421. Proc Natl Acad Sci USA 107: 1506-1511, 2010.
32. MANSOUR WY, BOGDANOVA NV, KASTEN-PISULA U, RIECKMANN T, KÖCHER S, BORGMANN K, BAUMANN M, KRAUSE M, PETERSEN C, HU H, GATTI RA, DIKOMEY E, DÖRK T and DAHM-DAPHI J: Aberrant overexpression of miR-421 downregulates ATM and leads to a pronounced DSB repair defect and clinical hypersen-sitivity in SKX squamous Cell carcinoma. Radiother Oncol 106: 147-154, 2013.
33. HAO J, ZHANG S, ZHOU Y, LIU C, HU X and SHAO C: MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochem Biophys Res Commun 406: 552-557, 2011.
34. LIVAK KJ and SCHMITTGEN TD: Analysis of relative Gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
35. GAO Y, LUO LH, LI S and YANG C: Mir-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression. Biochem Biophys Res Commun 444: 230-234, 2014.
36. SCHEE K, LORENZ S and WORREN MM: Deep sequencing the MicroRNA transcriptome in colorectal cancer. PLoS One 8: E 66165, 2013.
37. O'DONNELL KA, WENTZEL EA, ZELLER KI, DANG CV and MENDELL JT: C-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843, 2005.
38. SANCHEZ-DIAZ PC, HSIAO TH, CHANG JC, YUE D, TAN MC, CHEN HI, TOMLINSON GE, HUANG Y, CHEN Y and HUNG JY: De-regulated microRNAs in pediatric Cancer stem cells target pathways involved in Cell proliferation, Cell cycle and development. PLoS One 8: E61622, 2013.
39. GOWRISHANKAR B, IBRAGIMOVA I, ZHOU Y, SLIFKER MJ, DEVARAJAN K, AL-SALEEM T, UZZO RG and CAIRNS P: MicroRNA expression signatures of stage, grade, and progression in clear Cell RCC. Cancer Biol Ther 15: 329-341, 2014.
40. MANACH C, WILLIAMSON G, MORAND C, SCALBERT A and RÉMÉSY C: Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81: 230S-242S, 2005.
41. SHAHRZAD S, AOYAGI K, WINTER A, KOYAMA A and BITSCH I: Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J Nutr 131: 1207-1210, 2001.